Characterization and Identification of Some Medically Important Bacterial Isolates by Tiga, Suman
Characterization and identification of some 
medically important bacterial isolates 
 
A Dissertation 
Submitted in partial fulfillment 
 
FOR THE DEGREE OF 
MASTER OF SCIENCE IN LIFE SCIENCE 
 
 
By 
Suman Tiga 
(Roll No. 409LS2059) 
 
 
Under the guidance of 
Dr Surajit Das 
Assistant Professor 
Department of Life Science 
 
 
 
Department of Life science 
NATIONAL INSTITUTE OF TECHNOLOGY 
ROURKELA-769008(ORISSA) 
 
 
 
 
                                                         NATIONAL INSTITUTE OF 
TECHNOLOGY 
                                     Department of Life science 
                                     Rourkela-769008, Orissa, india                                   
 
Dr. Surajit Das, Ph.D 
Asst. Professor  
                                   
                                    
 
 
 
                                          CERTIFICATE 
 
 
 This is to certify that the dissertation entitled “Characterization and 
identification of some medically important bacterial isolates” 
Submitted by Ms. Suman Tiga, to the department of Life science, 
National Institute of Technology, Rourkela for the degree of Master 
of Science in Life science is based on the result obtains in the 
bonafide project work carried out by her under my Guidance and 
supervision.  
 
I further certify that to the best of my knowledge Suman Tiga bears a 
good moral character. 
 
 
 
Dr. Surajit Das 
(Asst. Professor) 
 
 
 
 
 
                                                 ACKNOWLEDGEMENT 
 
I owe this unique opportunity to place on record my deep sense of gratitude & 
indebtedness to my guide and supervisor Dr.Surajit Das, Assistant Professor, Department of 
Life Science, National Institute of Technology, Rourkela for his scholastic guidance, prudent 
suggestions & persistent endeavor throughout the dissertation.  
I also gratefully acknowledge to Dr. Samir Patra, Dr. Sujit Bhutia and Prof. Bismita 
Nayak, Depatment of Life Science, National Institute of Technology,Rourkela, for their 
wholehearted help and cooperation. 
I would also wish my thanks to Hirak Das (Ph.D. Scholar) for his ceaseless encouragement, 
prudent suggestions and timely advice during my work. 
             Lastly I express my abysmal adoration & heartfelt devotion to my beloved parents for 
their countless blessings, unmatchable love, affection & incessant inspiration that has given 
me strength to fight all odds & shaped my life, career till today. 
In the end I must record my special appreciation to GOD who has always been a 
source of my strength, inspiration & my achievements. 
 
 
                                                                        SUMAN TIGA 
 
 
 
                                                               
 
   
DECLARATION OF CANDIDATE 
 
             I hereby declare that the research work incorporated in this dissertation 
work entitled “Characterization and identification of some medically 
important bacterial isolates” is an authentic research work carried at Life 
science Department. National Institute of Technology, Rourkela under the direct 
guidance and supervision of Dr S Das. 
 
 
 
Date:      30.4.2011                                                        
 NIT Rourkela                                                               Ms  SUMAN TIGA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
Sl No. Subject Page No. 
1 
2 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Objective 
Review literature 
Klebsiella 
3.1.1. Infection caused 
3.1.2. Disease 
3.1.3. Clinical feature 
3.1.4. Pathogenesis 
3.1.5. Treatment 
3.1.6. Drugs resistance 
 
 3.2. Bacillus cereus 
3.2.1 Characterization 
3.2.2. Infection 
3.2.3.Clinical feature 
3.2.4. Treatment 
3.2.5. Pathogenesis 
 
3.3. E coli 
3.3.1. Disease diagnosis 
3.3.2.Symptoms 
3.3.3. Clinical feature 
3.3.4.Treatment 
 
3.4.Antimicrobial drug 
resistance 
3.4.1. Mechanism of 
resistance 
3.4.1. Mode of action of 
antimicrobial 
3.4.3. anticipating resistance 
1-4 
5 
 
6-10 
 
 
 
 
 
 
 
10-12 
 
 
 
 
 
 
12-16 
 
 
 
 
16-24 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5. Different antibiotic and 
their mode of action 
3.5.1 Tetracycline 
3.5.2 Chloramphenicol 
3.5.3 Vancomycin 
3.5.4.Amoxicillin 
3.5.5. Ciprofloxacin 
3.5.6. Penicillin 
3.5.7. kanamycin 
Materials and methods 
4.1. Collection of sample 
4.2. isolation of pure culture 
4.3.Biochemical analysis 
4.4. Antimicrobial 
susceptibility test 
4.4. McFarland standard 
4.5.1. Mc farland standard 
preparation 
4.5.2. use of the Mc Farland 
standard in the Kirby-bauer 
procedure 
4.6. preparation of Muller –
Hinton plate 
4.7. preparation of  
inoculums 
4.8.Inoculation of the MH 
plate 
4.9. placement of the 
antibiotic disks 
4.10.incubation of the plate. 
4.11. measuring zone sizes 
4.12. minimum inhibitory 
 
 
 
 
 
 
 
 
 
 
25-30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
5 
 
6 
 
7 
 
8 
 
9 
10 
 
11 
concentration test. 
4.13. preparation of serially 
diluted antimicrobial agent 
 
 
 Result analysis  
 
Discussion 
 
Conclusion 
 
Future prospects 
 
Appendix I 
Appendix II 
 
References 
 
 
 
 
 
 
 
 
 
 
 
 
 
31-39 
 
40-41 
 
42 
 
                     43 
 
44 
45 
 
                    46-51 
 
 
 
 
 
 
 
LIST  OF TABLES 
Sl.No Subjects Page No. 
1 
 
             2 
 
             3 
 
             4 
 
             5 
Enterobacteriaceae identification 
 
Carbohydrate utilization test 
 
Antibiotic disk diffusion result 
 
Antibiogram of disk diffusion test 
 
Minimum inhibitory concentration  result 
                 30-33 
 
34-35 
 
36 
 
36 
 
39 
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
LIST OF PHOTOGRAPHS 
Sl.No Subject Page No. 
1 
2 
3 
4 
5 
 
6 
7 
8 
9 
10 
11 
12 
13 
Tetracycline core structure 
Chloramphenicol core structure 
Action of chloramphenicol 
Vancomycin core structure 
Mode of action and mechanism 
of vancomycin 
Amoxcillin core structure 
Mode of action of amoxicillin 
Ciprofloxacin core structure 
Penicillin core structure 
Mode of action of penicillin 
Kanamycin core structure 
Biochemical analysis 
Result for antibiotic disc 
diffusion test 
17 
18 
19 
19 
20 
 
21 
21 
22 
23 
24 
24 
31 
37-38 
 
 
 
 
 
 
 
 
 
  
                                             ABSTRACT 
The study aimed to isolate and identify the bacterial isolate and determine the antibiotic 
sensitivity pattern of E coli, Klebsiella, Bacillus isolated from human patient. The sensitivity 
of E coli Klebsiella pneumoniae , Bacillus cereus were tested under different antibiotics like 
chloramphenicol, amoxcilin, vancomycine, tetracycline, penicillin, kanamycine, 
ciprofloxacin .E coli showed sensitive towards chloramphenicol and resistance to other 
antibiotics. Klebsiella pneumoniae also found to be resistance towards chloramphenicol and 
tetracycline and sensitive to others. Bacillus was intermediate to ciprofloxacine and 
amoxicillin and resistance to vancomycine cholaramphenicol and kanamycine.The goals of 
testing are to detect the possible drugs resistance in common pathogen to assist in treatment 
of particular infection 
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INTRODUCTION:- 
 A key threat to conservation as well as public health is emerging infectious diseases 
(Meffe 1999; Daszak et al. 2000). The term antimicrobial agent is used for agents that 
disrupt the normal physiology of a multicellular animal or plant.  
 Pathogens can  infect unicellular organisms of the biological kingdoms. A host can be  
invaded by several substrates and pathways whereby pathogens. A property of 
pathogenic microorganisms is “Primary invasiveness”  
  Infection is also the introduction or entry of a pathogenic microorganism into a 
susceptible host, whether or not it causes pathological effects or disease, but implies 
that the organism must enter the body of the host, usually the cells, and be able to 
reproduce to form new infective units.  
 Simply ingesting a pathogen does not imply infection. Pathogenicity is the ability of 
an organism to invade the host and cause disease.  
 This term is applied to groups or species of microorganisms, whereas virulence is 
used to compare the degree of pathogenicity within the group or species. 
 Microbes are living organisms that reproduce, thrive, and spread quickly and 
efficiently increasing their numbers.  
 Microbes include bacteria (Bacillus cereus), viruses (colds and influenza, which 
causes the "flu"), fungi (e.g.,Candida albicans, which causes some yeast infections), 
and parasites (e.g., Plasmodium falciparum, which causes malaria).  
 The general term given to medicines that kill or slow the growth of microbes is 
Antimicrobial. The ability of a microbe to grow in the presence of a chemical that 
would normally kill it or limit its growth is the Antimicrobial drug resistance.  
 Bacteria evolution towards resistance to antimicrobial drugs, including multidrug 
resistance, is unavoidable because it represents a particular aspect of the general 
evolution of bacteria that is unstoppable. Therefore, the only means of dealing with 
this situation is to delay the emergence and subsequent dissemination of resistant 
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bacteria or resistance genes. Mutations in housekeeping structural or regulatory genes 
can result in increased resistance to antimicrobial drugs in bacteria. 
 Scottish scientist Alexander Fleming noticed that a type of mold growing by accident 
on a laboratory plate was protected from, and even repelled, the bacteria in 1928 
while working with Staphylococcus bacteria.  
 Fleming called penicillin a active substance, was literally an antibiotic - it killed living 
organisms. Thus began the age of using natural and, later, synthetic drugs to treat 
people with bacterial infections.  
Drug resistance: 
Disease-causing microbes evolution has resulted in many antimicrobials losing their 
effectiveness after more than 50 years of widespread use. As microbes evolve, they adapt to 
their environment. The microbes evolve new mechanisms to resist the antimicrobials by 
changing their genetic structure from something that stops them from growing and spreading-
such as an antimicrobial. The genetic structure changes ensure that the offspring of the 
resistant microbes are also resistant. It is to harder to eliminate infections from the body due 
to antimicrobial resistance. A microbe's ability to survive along antimicrobials, some 
infectious diseases is now more difficult to treat than a few decades ago.  
Causes of antimicrobial drug resistance 
Microbes, such as bacteria, viruses, fungi, and parasites, are living organisms that evolve over 
time. Their primary function is to reproduce, spread-quickly and efficiently. Due to this 
reason the microbes adapt to their environment that ensure their survival. Something stops 
their ability to spread, genetic changes can occur that enable the microbe to survive. 
 Antimicrobial resistance in micro-organisms  
The antimicrobial resistance mechanisms are described by using four categories:  
1. Based on the structural nature of micro-organism‟s outer membrane which is considered to 
be a barrier for drug‟s entry into the cell Bypass‟ was described. Mycobacterium outer cell 
wall of makes these bacteria resistant to many antimicrobials (Nikaido, 1994).  
2. Enzymatic modification or inactivation of the antimicrobial agent. The β-lactamase 
enzymes in E. coli (Jacoby, 1994), which  destroys the β-lactam-ring‟s of the penicillin; or, 
amino glycoside-modifying enzymes in Staphylococcus aureus. 
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3. The antimicrobial resistance developed by organism through structural changes of the drug 
target sites (for example, mutations in the genes) lead to a structure of changed drug target 
sites that inhibit drugs from binding to these target sites (Webber and Paddock, 2001).  
4. The self-defense mechanism of a micro-organism is a efflux pump whereby a drug that 
initially enters the cell through the cytoplasmic membrane is subsequently transported, 
actively, out of the cell before it can contact the action site and exert its effect (Tenover, 
2006). The efflux system requires energy therefore it is consider to be a pump. This 
mechanism occurs in many natural resistance of various and specific organisms (Bambeke, et 
al. 2006) for example tetracycline. (Ramon-Garcia, et al. 2006). Or fluroquinolones 
(Bambeke, et al. 2006). 
 
CLASSIFICATION OF MICROORGANISM:- 
                    Klebsiella                   kingdom     :    Bacteria 
                                                        Phylum    :    Proteobacteria 
                                                        Class        :   Gammaproteobacteria 
                                                        Order       :    Enterobacteriales 
                                                         Family    :    Enterobacteriaceae  
                                                        Genus       :    Klebsiella    
                                                        Species      :    K. Pneumonie 
                     E.coli                kingdom  :    Bacteria 
                                                         Phylum     :     proteobacteria 
                                                         Class         :     Gammaproteobacter 
                                                         Order        :     Enterobacteriales 
                                                         Family      :     Enterobacteriaceae 
                                                         Genus       :     Escherichia 
                                                         Species      :     E.coli 
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                   Bacillus                         Kingdom     :     Bacteria 
                                                           Phylum    :     Firmicutes 
                                                           Class        :     Bacilli 
                                                           Order        :    Bacillales 
                                                           Family      :      Bacillaceae 
                                                           Genus       :     Bacillus 
                                                           Species      :    B. cereus 
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  OBJECTIVES: 
 
 Isolation of pure culture of pathogen (Klebseilla, E.coli, Bacillus) 
 Antibiotic disc diffusion test 
 Biochemical characterization 
 Determination of Minimum inhibitory concentration (MIC) of 
antibiotics. 
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REVIEW LITERATURE 
3.1. Klebsiella 
                        Klebsiella is a non-motile, Gram-negative, oxidase-negative, rod-shaped 
bacteria with a prominent polysaccharide-based capsule. It is named after the German 
microbiologist Edwin Klebs (1834–1913).It is a type of Gram-negative bacteria that causes 
different types of healthcare-associated infections, including pneumonia, bloodstream 
infections, wound or surgical site infections, and meningitis. It is found that Klebsiella  
developed antimicrobial resistance, most recently to the class of antibiotics known as 
carbapenems. Klebsiella bacteria are found in the human intestines (where they do not cause 
disease). They are also found in human stool (feces).  Klebsiella infections  occur among sick 
patients who are receiving treatment for other conditions. Patients who require devices like 
ventilators (breathing machines) or intravenous (vein) catheters, and patients who are taking 
long courses of certain antibiotics are most at risk for Klebsiella infections. Healthy people 
usually do not get Klebsiella infection. 
3.1.1. Infection Cause 
 Klebsiella bacteria can be spread through person-to-person contact  or, less commonly, by 
contamination of the environment. The bacteria are not spread through the air. Patients in 
healthcare settings can also be effected Klebsiella when they are on ventilators (breathing 
machines), or have intravenous (vein) catheters or wounds (caused by injury or surgery). 
These medical tools and conditions allow Klebsiella to enter into the body and cause 
infection.  
3.1.2.. Disease  
Klebsiella can cause serious infections that may often be fatal. Drug-resistant pneumonia, 
chronic nasal infections, bronchitis and urinary tract infections,  even gangrene are some of 
the infections these common bacteria can cause in susceptible people.In the  Pneumonia, 
urinary tract infections, septicemia, ankylosing spondylitis,  urinary tract infections and soft 
tissue infection actions can spread rapidly and are most often acquired in the hospital while 
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being treated for other illnesses or surgical procedures. The main sources of Klebsiella 
infections are due to the hands of hospital staff and the gastrointestinal tract of patients.
 
 pneumonia (lung infection)  
 bloodstream infection  
 wound infection, and  
 meningitis  
 Klebsiella pneumonia, are rare and severe disease with dark brown or red 
currant–jelly sputum, lung abscess formation and empyema, is most common 
among diabetics and alcoholics.   
 
3.1.2.1. Urinary infections are the common conditions, especially in, the elderly pregnant 
women and babies. The symptoms are minor and can often be confused with other 
conditions. However, if left untreated, urinary tract infections causes serious medical 
conditions, including infections that leave irreparable damage to the kidneys. Klebsiella,  
resistant to several kinds of antibiotics, is often the cause of complicated urinary infection. 
3.1.2.2. Diarrhea may be found in immunocompromised individuals. Rhinoscleroma, a the 
chronic inflammatory disease of the nasopharynx and respiratory system is rarely fatal but 
can cause deformities of the nose. 
3.1.3. Clinical Feature 
The most clinically important species of the genus is klebsiella pneumonia. This large,non- 
motile bacterium the
 
most
 
clinically
 
important
 
species of this genus is Klebsiella pneumoniae. 
This large, non-produces large sticky colony when plated on nutrient media. Klebsiella's 
pathogenicity can be caused due to its production of a heat-stable enterotoxin. K. pneumoniae 
infections are common in the hospitals where they cause and urinary tract infections 
pneumonia in catheterized patients. In fact, K. pneumoniae is second only to E. coli as a 
urinary tract pathogen. It may be due to probable due to the bacterium's antibiotic resistance 
properties. Klebsiella may develop resistance plasmids (R-plasmids) which cause resistance 
to such antibiotics as ampicillin and carbenicillin. Klebsiella pneumonia affects people 
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experiencing diseases, such as alcoholism, diabetes and chronic lung disease. Klebsiella 
pneumonia causes  rapid-onset illness that often causes areas of destruction in the lung.  
Infected persons generally get, chills, flu-like symptoms high fever  and a cough productive 
of a lot of mucous. The mucous (or sputum) that is coughed up is often thick and blood 
tinged and has been referred to as "currant jelly" sputum due to its appearance. Klebsiella 
pneumonia  causes mostly lung destruction and pockets of pus in the lung (known as 
abscesses). Klebsiella generally has two types of antigens on the surface of the cell, 
lipopolysaccharide (O antigen) and capsular polysaccharide (K antigen), both contributing to 
pathogenicity. Host defense against bacterial invasion by phagocytosis by polymorphonuclear 
granulocytes and the bactericidal result of serum,mainly mediated by complement proteins. 
Preclinical studies plays an role for neutrophil myeloperoxidase and lipopolysaccharide-
binding protein in host defense against K pneumoniae infection. Neutrophil myeloperoxidase 
mediate oxidative inactivation of elastase, an enzyme involved in the pathogenesis of 
different tissue destroying infections. The bacteria defeat natural host immunity by various 
means, as they hold a polysaccharide capsule, which is the major determinant of their 
pathogenicity. The capsule layer provides protection from phagocytosis by 
polymorphonuclear granulocytes and avoids bacterial death from bactericidal serum factors. 
The numerous adhesins produced by the bacteria is responsible for the microorganism to hold 
on to host cells, which is crucial to the infectious process. Klebsiellae are everywhere in 
nature, while in humans they can inhabit the skin, pharynx or gastrointestinal tract and also 
sterile wounds and urine. K pneumoniae and K oxytoca are members of the genus that cause 
most human infections and they can found in the environment and in mammalian mucosal 
surfaces. Klebsiella infections is the gastrointestinal tract of patients and the hands of hospital 
staff Klebsiella infection takes place in the lungs, causing devastating changes and generally 
affects old or middle aged men with weakening diseases, such as diabetes or alcoholism. 
Klebsiella is also responsible for nosocomial infections in such sites as urinary tract, , lower 
respiratory tract biliary tract, or surgical wound sites. Apparatus, urinary catheters, pollution 
of respiratory support equipment, and the use of antibiotics are also increasing the probability 
of nosocomial infection with various Klebsiella species. ozena an Rhinoscleroma d  are two 
other rare infections set off by Klebsiella species. The extensive use of  antibiotics in 
hospitalized patients resulted in an amplified carriage of klebsiella and the appearance of 
multidrug-resistant strains. Klebsiella pneumonia is having an increased mortality rate of 
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roughly 50% including in the case of antimicrobial therapy. Even more, the mortality rate is 
close to 100% for people with alcoholism and bacteremia. 
3.1.4. Pathogenesis 
The most common Klebsiella infection is pneumonia and it which causes 50 percent 
mortality rate with it, even with antimicrobial treatment. Klebsiella pneumonia‟s Symptoms 
are, fever, flu-like symptoms, chills and a cough along with thick mucus mixed with blood. 
Klebsiella  attack the lung tissue that causes pus to surround the lung causing scar tissue to 
form. This is very serious and may require surgery to fix. Klebsiella even infects the urinary 
tract and can enter the body through wounds. Contact with the fecal matter is an significant 
source of infection. Patients with invasive devices such as feeding tubes, central venous 
catheters indwelling catheters and who are generally in poor health are at particular risk for 
contracting a Klebsiella infection. Those with alcoholism, lung disease and diabetes are also 
effected . A Klebsiella infection may need two powerful antibiotics as the bacteria are 
resistant to penicillin and many others, due to excessive use by hospitals of broad-spectrum 
antibiotics. 
 
3.1.5. Treatment 
Klebsiella infections which are not drug-resistant can be treated with antibiotics. A 
microbiology laboratory must tests to determine which antibiotics will treat the infection. 
Klebsiella is mainly a nosocomial infection, which are generally hospital-acquired infections. 
If an infection appears after 48 hours or more after hospital admission or within 30 days of 
discharge, it is considered to be nosocomial.  
3.1.6. Drug Resistance 
Klebsiella infections are often treated with third-generation cephalosporins, carbapenems, 
fluoroquinolones or aminoglycosides. It is needed to determine the appropriate antibiotic, as 
some strains may become resistant to multiple antibiotics. 
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3.1.6.1. Beta-lactamase inhibitors 
Some bacteria release an enzyme called beta-lactamase, which renders penicillin ineffective. 
A beta-lactamase  prevents the enzyme from forming and allows the penicillin to perform its 
function. Timenti Unasyn,n and Zosyn are all penicillins with beta-lactamase inhibitors, 
according to Drugs.com. Intravenously medicine is given to patients with Klebsiella 
pneumoniae. Side effects include, headaches, stomach upset diarrhea  and possibly vomiting 
although these medications are usually tolerated well. It should not be taken by the patient 
who are allergic to penicillin. Enzymatic inactivation and modification of the antimicrobial. 
For example, the secretion of the β-lactamase enzymes in E. coli (Jacoby, 1994), which 
breaks the β-lactam-ring‟s chemical structure of the penicillins 
3.2. Bacillus cereus  
3.2.1. Characterization 
Characteristically, Bacillus cultures are the Gram-positive when it is young, but may become 
Gram-negative as they age. Bacillus species are sporulating aerobic, , rod-shaped bacteria 
which are ubiquitous in nature. Gram-stained cells, 1 µm long, arranged singly or in short 
chains. Bacillus cereus is spore-forming bacterium that can be frequently isolated from soil 
and some food. B. cereus spores are mostly resistant to heat and chemical treatments than 
vegetative pathogens such as Salmonella, Campylobacter, E. coli, and Listeria 
monocytogenes (Johnson, K.M. 1984) If B. cereus can cause two different types of food-
borne illness in humans – vomiting very shortly after eating contaminated food or diarrhoea 
after a longer incubation. Bacillus cereus is a cause of food poisoning that is mainly 
associated with the consumption of rice-based
 
dishes. The organism produces an diarrheal 
syndrome 
 
induced by an emetic toxin and enterotoxin, respectively. Other
 
toxins are 
produced during growth, including,
 
proteases, phospholipases and hemolysins, one of which, 
cereolysin, is a thiol-activated
 
hemolysin (Gilbert et al, 1979). These toxins may contribute to 
the pathogenicity
 
of B. cereus is non gastrointestinal disease (Blakistone et al, 1999). B. 
cereus are often isolated
  
from clinical material other than feces or vomitus was 
commonly
 
dismissed as a contaminant, but increasingly it is being recognized
 
as a species 
with pathogenic potential. It causes  serious non gastrointestinal infection,
 
particularly in drug 
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addicts, the immunosuppressed, neonates,
 
and postsurgical patients, especially when 
prosthetic implants
 
such as ventricular shunts are inserted. Ocular infections are 
 
the severe 
infection, including endophthalmitis,
 
panophthalmitis, and keratitis, usually with the 
characteristic formation of corneal ring abscesses (Aas et al, 1992) all though prompt 
surgical
 
and antimicrobial agent treatment, enucleation of the eye and
 
blindness are common 
sequelae. meningitis, osteomyelitis, endocarditis,
 
 Septicemia, and surgical and traumatic 
wound infections are
 
other manifestations of severe disease (Shinagawa et al, 1993). B. 
cereus produces beta-lactamases, and so is resistant to beta-lactam
 
antibiotics; it is usually 
susceptible to treatment with clindamycin, vancomycin, gentamicin, chloramphenicol, and 
erythromycin. Simultaneous
 
therapy via multiple routes may be required. 
3.2.2. Infection 
Bacillus cereus causes a toxin-mediated food poisoning. Bacillus cereus is an gram-positive 
aerobic and facultative anaerobic, spore-forming, bacillus.A preformed heat stable toxin 
causes the emetic syndrome. The diarrhoea syndrome is caused by in vivo production of heat-
labile enterotoxins. 
 
3.2.3. Clinical Features 
There are two clinical syndromes caused by food poisoning: 
The diarrheal form of illness: 
1. Bacillus cereus is having a longer incubation (6 to 24 hours) period similar to that of 
Clostridium perfringens watery diarrhoea, moderate to severe abdominal cramps and 
vomiting in about one fourth of the patients. Duration of illness is for 20-36 hours, 
with a median of 24 hours. Associated with meat dishes. 
2. The emetic form of illness: 
Bacillus cereus is having a very short incubation period (1 to 6 hours), similar to that of 
staphylococcal food poisoning. Vomiting and abdominal cramps. Diarrhoea is present in only 
about a third of affected individuals. Duration of illness is for 8 to 10 hours, with a median of 
9 hours. Of illness. Associated with rice dishes. 
3.2.4. Treatment 
B.cereus food poisoning in person require only supportive treatment. Oral rehydration, 
intravenous fluid and electrolyte replacement for patients with severe dehydration is 
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indicated. Antibiotics are not indicated. Patients who are affected by the invasive disease 
require antibiotic therapy and prompt removal of any potentially infected foreign bodies. 
Bacillus cereus is usually susceptible in vitro to vancomycin, clindamycin. (Kramer et al, 
2001) 
3.2.5. Pathogenesis 
B. cereus is responsible for a minority of food borne illnesses (2–5%), causing severe nausea, 
vomiting and diarrhoea (Kotiranta et al, 2000). Due to survival of the bacterial endospores 
Bacillus food borne illnesses will occur, when food is improperly cooked? (Turnbull PCB 
1996). Cooking temperatures less than or equal to 100 °C (212 °F) allows some B. cereus 
spores to survive. Germination and growth generally occurs between 10–50 °C (50–122 °F), 
though some strains are psychotropic (Davis et al, 2008). Production of enterotoxins results 
in Bacterial growth, one of which is highly resistant to heat and to pH between 2 and 11; 
ingestion leads to two types of illness, diarrheal and emetic (vomiting) syndrome.(Ehling-
Schulz  et al, 2004).  The diarrhoeatic syndromes observed in patients are thought to stem 
from the three toxins Hemolysin BL  Hbl,  Nonhemolytic Enterotoxin  Nhe and  Cytotoxin 
K Cytk(Guinebretière  et al,2002). On the chromosome of the bacteria the genes 
nhe/hbl/cytK  are located. Transcription of these genes is controlled by PlcR. These genes 
occur as well in the taxonomically related B. thuringensis and B. anthracis. The Hbl and Nhe 
are the  pore-forming toxins that are  closely related to ClyA of E. coli. 
 
3.3. E  Coli  
The total coliform and fecal colifom are referred to as indicator organism because a 
quantization of their presence is used to indicate the potential presence of 1 5 pathogens in 
foods. The fecal coliform group includes rod-shaped, Gram-negative, non-spore forming 
organisms that live in the gastrointestinal tract of humans and other warm blooded animals, 
ferment lactose at 44.5
o
C within 48 hour. A member of the fecal coliform group is 
Escherichia coli (Oram, 2005). The name Escherichia comes from the name of the 
paediatrician Escherich. Who in 1895 first isolated and characterized this bacterium as 
“bacterium coli commune” („enteric bacteria‟) (Todar, 2005). Its involvement in several cases 
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of food poisoning has suggested that E. coli should be used as an indicator for sanitary 
quality.  E. coli is an inhabitant of the intestine tract of humans and animals as well as in the 
environment, water and food. The presence of E. coli in food or water is an indication of 
uncleanliness and careless handing. It also implies that enteric pathogens may be present 
(Fratamico and Smith, 2006).  The limits of temperature for growth of E. coli are 7-46°C and 
the optimum growth temperature is approximately 37°C but E. coli can survive for weeks at -
20°C to 4°C. E. coli generally grows within the pH range of 4.4–9.0 (Bell and Kyriakides, 
1998). 
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E. coli grows very quickly and the generation time in the intestine is thought to be about 12 
hours. Under optimum conditions the generation time is 20 minutes. Some strains of E. coli 
bacteria produce an enzyme called extended-spectrum β-lactamase (ESBL) which helps E. 
coli resist to many types of antimicrobials. Among all the strains of E. coli some strains, some 
are useful for producing sources of „B‟ and „K‟ vitamins for the host and some are harmless 
to hosts but some strains can cause illness such as urinary tract infections, meningitis, 
peritonitis, mastitis, septicemia and Gram-negative pneumonia. E. coli has three kinds of 
antigens including „H‟ or flagellar antigens, „O‟ or somatic antigens which are the 
lipopolysaccharide complexes and „K‟ or the capsular antigens which are mainly acidic 
polysaccharide (Todar, 2005). E. coli strains can cause illness such as enteroinvasive E. coli 
(EIEC), entero-toxigenic E. coli (ETEC), entero-pathogenic E. coli (EPEC) and entero-
hemorrhagic E. coli (EHEC) (Fratamico and Smith, 2006). Escherichia coli (E. coli) are a 
group of genus of Gramnegative, anaerobic, rod-shaped bacteria, which inhabits the intestine 
of all healthy humans and most warm blooded animals. There are many strains of E. coli 
bacteria and most of them are harmless and serves a useful function in the body by 
suppressing the growth of harmful bacterial species and by synthesizing appreciable amounts 
of vitamins. A very few strains E. coli are having the capability of causing human illness by 
several different mechanisms. This is the case of Escherichia coli O157 which is the most 
frequent and virulent. This serotype belongs to the enter hemorrhagic E. coli (EHEC) group. 
EHEC bacteria contain one or more virulent attributes as:  The ability to produce shiga-like 
toxin(s) also called verotoxin(s)  Adherence factors which enable the organism to attach to 
and to colonize intestinal mucosal cells  Enterohemolysin  Chromosomal eae gene which 
encodes the production of intimin (an adherence marker). E. coli O157 was first identified as 
a human pathogen capable of causing foodborne illness in 1982. However, the public was 
generally unaware of the existence of O157 until a decade later when a large outbreak 
occurred. Therefore, the focus of most research has been on the serotype O157:H7.. 
Excluding O157, the most commonly implicated sero-groups include O26, O103, O111 and 
O145. 
3.3.1. Disease Diagnosis: 
Microscopy studies in stool samples will show Gram negative rods, with no particular cell 
wall. Stool is inoculated on the either MacConkey agar or EMB agar (or both). Deep red 
colonies are produced on the surface of MacConkey agar, as the organism is lactose-positive, 
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and fermentation of this sugar will cause the medium's pH to drop, leading to darkening of 
the medium. This is diagnostic of E. coli. Mammalian cells in tissue culture are used for the 
tests for toxin production, which are rapidly killed by shiga toxin. , This method is very slow 
and expensive ,although sensitive and very specific.
 
(Johnson et al, 2006).  
 Gastrointestinal infection 
Transmission of pathogenic E. coli often occurs via fecal-oral transmission.
 
(Gehlbach et al, 
1973) Common routes of transmission include: unhygienic food preparation, farm 
contamination due to manure fertilization, (Russell, 2006). Irrigation of crops with 
contaminated grey water or raw sewage
 
(Heaton, 2008). Feral pigs on cropland,( Thomas, et 
al 2007-08)
 
 or direct consumption of sewage-contaminated water.( Chalmers et al,  
2000. Food products associated with outbreaks of E. coli  include raw ground beef, raw seed 
sprouts or spinach. Cooking the food properly, preventing cross-contamination, instituting 
health care policies so food industry employees seek treatment when they are ill, 
pasteurization of juice or dairy products and proper hand washing requirements will cause the 
disruption faecal-oral cycle of transmission. 
Neonatal meningitis 
 A serotype produced by Escherichia coli that contains a capsular antigen called K1. The 
newborn's colonisation in the  intestines with these stems, that are present in the mother's 
vagina, lead to bacteraemia, which leads to meningitis. The IgM antibodies absence of the  
from the mother, plus the fact that the body recognises as self the K1 antigen, as it resembles 
the cerebral glycopeptides, this leads to a severe meningitis in the neonate. 
3.3.2. Symptoms 
Bloody diarrhea is the main symptom of an E.coli infection. You may also 
havestomach cramps and nausea and vomiting. Some people do not notice any symptoms. 
Children are more likely than adults to have symptoms. Usually symptoms start 3 or 4 days 
after you come in contact with the E. coli. Most people get better in about a week. They often 
don't see a doctor and don't know that E. coli caused their problems.  
3.3.3. Clinical feature 
  HUS is the reason of acute kidney failure in children. The infection may be caused by a very 
small dose which can be as few as 50-100 bacteria. The disease caused by E. coli O157:H7 is 
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hemorrhagic colitis and is characterized by severe cramping (abdominal pain) and diarrhoea 
(watery and/or bloody). Other symptoms may include vomiting and low-grade fever. The 
illness is usually self-limited and lasts an average of 8 days. Sometimes the infection causes 
non-bloody diarrhoea or no symptoms at all. Serious complications occur in 0 to 15% of 
cases and are experienced more frequently by the children less than five years of age and the 
elderly. These complications are haemolytic uremic syndrome -in which the red blood cells 
are destroyed and the kidney fail- and thrombotic thrombocytopenic purpura (TTP) which is 
characterized by HUS plus fever and neurologic symptoms. TTP has a mortality rate as high 
as 50%. 
 
3.3.4. Treatment 
Without antibiotics  most people can recover within 5 to 10 days. The diarrhoea occurs for a 
few days but it is important to drink plenty of fluids to prevent dehydration (fluid loss). The 
treatment with some antibiotics may precipitate kidney complications but there is no proper 
evidence that antibiotics improve the course of disease. Blood transfusions and kidney 
dialysis are often required. The death rate for haemolytic uremic syndrome is only 3%-5%. 
3.4. ANTIMICROBIAL DRUG RESISTANCE 
The arsenal of available drugs against protozoal pathogens has been severely limiting  the 
emergence of drug resistance. The toxicity of drugs have been  evolved (Box) by parasites in 
numerous ways to overcome. Mutations in the drug target so that the binding of the  drug or 
inhibit the target are due to the Drug resistance. Where a single point mutation can confer 
resistance ,drug resistance can develop quickly in situations.  
3.4.1. MECHANISM OF RESISTANCE 
1. Antimicrobial agent‟s altered permeability 
2. Inactivation of the antimicrobial agent  
3. Altered target site  
4. Replacement of a sensitive pathway  
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3.4.2.. Mode of action of antimicrobials  
An antimicrobial (either bactericidal or bacteriostatic) has an effect on micro-
organisms antimicrobially when it interferes well with their site of activity. Antimicrobial 
mechanisms of action are (Abedon, 2003):  
 
● Interference with cell wall synthesis: 
● Protein synthesis inhibition  
● Interference with nucleic acid synthesis: 
● Bacterial membrane structure disruption 
3.5. Different antibiotics and their mode of action 
3.5.1. Tetracyclines 
Tetracyclines have the antimicrobial activity. These may include: Aureomycin, Terramycin, 
and Panmycin. There are 4 fused 6-membered rings, as shown in the figure below, that form 
the basic structure from which the various tetracyclines are made. Different derivatives are 
different at one or more of four sites on the rigid, planar ring structure. Streptomyces spp., 
gives classical tetracyclines but the newer derivatives are semi-synthetic as is 
generallytruefor newer members of other drug groups. (Fig 1). 
 
     Fig-1: Tetracycline core structure. 
 
 
 Mechanism of Action 
Bacterial protein synthesis is inhibited by tetracyclines by blocking the attachment of the 
transfer RNA-amino acid to the ribosome. They are the inhibitors of the codon-anticodon 
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interaction. Protein synthesis in the host can be inhibited by Tetracyclines, but are less likely 
to reach the concentration required because eukaryotic cells do not have a tetracycline uptake 
mechanism. 
3.5.2. Chloramphenicol 
Chloramphenicol is an antibiotic that possesses activity similar to the tetracycline. It is the 
only antibiotic prepared synthetically. For the treatment of serious infections it is reserved 
because it is potentially highly toxic to bone marrow cells. Protein synthesis has been 
inhibited by attaching to the ribosome and interferes with the formation of peptide bonds 
between amino acids. Chloramphenicol acts as an anti-metabolite for the essential amino acid 
phenylalanine at ribosomal binding sites. (Fig 2). 
  
                                        
                       Fig-2: Chloramphenicol core structure. 
 
Mechanism of Chloramphenicol  
 
a) Inhibits protein synthesis by binding to a subunit of the bacterial ribosome  
b) blocks cross-linking of the cell wall structure  
c) inhibits enzymes needed in the biosynthesis of folic acid  
d) inhibits bacterial DNA gyrase  
e) inhibits DNA-dependent RNA polymerase(Fig 3) 
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Fig-3: Action of Chloramphenicol. 
3.5.3. Vancomycin 
Vancomycin   is an antibiotic that is a glycopeptide   used in the prophylaxis and treatment of 
infections may be caused by Gram-positive bacteria. It is used  as a drug of "last resort", and 
it is used only after treatment with other antibiotics had failed, although the emergence of 
vancomycin-resistant organisms means that it is increasingly being displaced from this role 
by  linezolid  (Zyvox) available PO and IV and  daptomycin (Cubicin) IV 
and quinupristin/dalfopristin .(Fig 4) 
                                
                                 Fig-4: Vancomycin core structure. 
Mode of action and mechanism of resistance 
1. Vancomycin has been to the bacterial environment while the bacterium is trying to 
synthesize new cell wall. The cell wall strands have been not yet cross-linked but are 
synthesized.  
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2. Vancomycin can recognize and bind on the end of the peptide chains of the two D-ala 
residues. The D-lactate replaces the last D-ala residue, so vancomycin cannot binding 
resistant bacteria.        
 3. In resistant bacteria, cross-links are successfully formed. However, the vancomycin bound 
to the peptide chains prevents them from interacting properly with the cell wall cross-linking 
enzyme, in the non-resistant bacteria. 
4. In the resistant bacteria, stable cross links are formed (Fig 5). 
 
Fig-5: Mode of action and mechanism of vancomycine. 
         
3.5.4.. Amoxicillin 
Amoxicillin belongs to a class of penicillins. Other members are as follows 
: ampicillin (Unasyn), piperacillin (Pipracil), ticarcillin (Ticar) and several others. These 
antibiotics all have a similar mechanism of action. They do not kill bacteria, but stops 
bacteria from multiplying by preventing bacteria from forming the walls that surround them. 
Bacteria cannot survive without a cell wall. Amoxicillin acts against many different bacteria 
including  N. gonorrhoea ,  H. influenzae, Pneumococci, E. coli, Streptococci, and certain 
strains of Staphylococci.(Fig 6) 
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                               Fig-6: Amoxcillin core structure. 
 Mechanism of action 
Amoxicillin binding occurs at the site Penicillin-binding protein 1A (PBP-1A) located inside 
the bacterial cell well. Penicillins helps in acylating  the penicillin sensitive transpeptidase C-
terminal domain by opening the lactam ring. Prevention of  the formation of a cross-link of 
two linear  peptidoglycan strands, inhibiting the third and last stage of  bacterial cell wall  
synthesis is due to the inactivation of the enzyme. Bacterial cell wall autolytic enzymes  such 
as autolysins mediates cell lysis by; it is possible that  amoxicllin interferes with an autolysin  
inhibitor (Fig 7) 
              Fig 7: Mechanism of action. 
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3.5.5. Ciprofloxacin 
Ciprofloxacin: Rapid bactericidal activity and high potency are its characteristics. It spares 
protective intestinal streptococci and anaerobes. It is active against many Beta lactum and 
amino glycoside resistant bacteria. At acidic pH it is less active. It has low frequency of 
mutational resistance and low propensity to select plasmid resistant mutants. Ciprofloxacin is 
used for treating certain bacterial infections. It belongs to the class of fluoroquinolones. It is 
present available in both tablet and suspension (liquid) form for the treatment of  various 
diseases like bronchitis, diarrhoea, sinus, urinary tract infections etc..(Fig 8). 
 
                         
               Fig 8: Ciprofloxacin core structure. 
 Mechanism of Action 
Inhibition of topoisomerase enzymes, inhibits relaxation of supercoiled  DNA and promotes 
breakage of double stranded DNA. The drug acts by decreasing the rate of multiplication of 
bacteria by stopping the reproduction and repair of their genetic material or (DNA) 
3.5.6. Penicillin 
Penicillium fungi is a microbe that helps in derivation of Penicillin  - group of antibiotics  . 
penicillin G,procaine penicillin, benzathine penicillin, and penicillin V are included under 
this group. Penicillin antibiotics are the first drugs that were effective against many 
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previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are 
most widely used today, though many types of bacteria are now resistant. All penicillins 
comes under the category of beta-lactam antibiotics and are used in the treatment of 
bacterial infections caused by susceptible, usually Gram-positive, organisms (Fig 9) 
                                                         
                                                Fig 9: structure of penicillin. 
Mode of action 
Cross-links formation of the bacterial cell wall by a penicillin binding protein (PBP, an 
enzyme) and subsequent suicide inhibition by penicillin. 
1. The bacterial cell wall consists repeating units of N-acetylglucosamine (NAG) and N-
acetylmuramic acid (NAM) subunits. The subunits of NAM have short peptide chains 
attached to them.  
2. The PBP forms the cross-link and binds the peptide side chains. 
3. The PBP the cross-link has been formed and dissociates from the wall once. 
4. Penicillin enters the active site of the PBP is added to the system. 
5. The beta-lactam ring  springs open and penicillin covalently binds to the PBP, permanently 
blocking its active site (Fig 10). 
 
 
 
24 
 
                                   
                                  Fig 10: Mode of action. 
 
3.5.7. Kanamycin 
Kanamycin is an amino glycoside antibiotic. Sensitive bacteria can be killed by its action by 
stopping the production of essential proteins needed by the bacteria to survive (Fig 11) 
                                 
                                  Fig 11: Kanamycin core structure. 
Mode of Action 
Bacteriocidal.It is capable of diffusing through the porin channels in the outer membrane of 
gram-negative bacteria. Three ribosomal proteins will be interacting with it that enables 
inhibiting protein synthesis and increasing translation errors. 
Mechanism of Resistance 
Bacterial aminophosphotransferases (APHs) inactivates Kanamycin .The APHs can 
inactivate the actions of kanamycin by transfer of the γ-phosphate of ATP to the hydroxyl 
group in the 3' position of the pseudosaccharide. The Kan
R
 gene codes for kanamycin 
resistance. 
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MATERIAL AND METHODOLOGY 
4.1 .COLLECTION OF SAMPLE: 
 Various pathogenic strains were collected from ispat general hospital, Rourkela. 
4.2 ISOLATION OF PURE CULTURE: 
Pure cultures of the pathogens were isolated by using nutrient agar plate. That pure culture 
was used for biochemical analysis, antibiotic test, MIC test. 
4.3. BIOCHEMICAL ANALYSIS: 
Biochemical identification kit was used for the identification o the species of the pathogenic 
strain. The kit used are a) enterobactericeaae identification kit (part I, part II), b) carbohydrate 
utilization test kit (part A, part B, part C). Biochemical Identification test kit is a standardized 
colorimetric identification system utilizing conventional biochemical tests and carbohydrate 
utilization tests. Based on the pH change and substrate utilization the tests are done. On 
incubation metabolic changes occur organisms which are indicated by a colour change in the 
media that is either interpreted visually or after addition of a reagent. 
4.4. Antimicrobial susceptibility test: 
Kirby-Bauer disk diffusion method was used to test the susceptibility of the pathogen isolates 
to different antimicrobial agents: ampicillin (30 μg), tetracycline (30 μg), chloramphenicol 
(30 μg), vancomycin (30 μg), kanamycin (30 μg), ciprofloxacin (30 μg), The inocula were 
prepared by growing the various pathogen on separate agar plates and colonies from the plate 
were transferred with inoculating loop into 3 ml of normal saline in a test tube. The density of 
these suspensions was adjusted to 0.5 McFarland standards. The surface of Muller-Hinton 
agar plate was evenly inoculated with the organisms using a sterile swab. The swab was 
dipped into the suspension and pressed against the side of the test tube to remove excess 
fluid. Using the wet swab inoculation was done in the Muller-Hinton agar by evenly 
streaking across the surface. By means of Disc Dispenser the antibiotic discs were applied to 
the surface of the inoculated agar and the plates were incubated overnight at 37 
0
C. The zone 
of growth-inhibition‟s  diameter was  observed and measured and compared to the chart 
provided by National Committee for Clinical Laboratory Standards (NCCLS). 
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4.5. McFarland standard  
McFarland standards include the suspensions of either barium sulfate or latex particles that 
helps for visual comparison of bacterial density. Now-a-days in the market , commercially 
prepared standards are available for purchase from companies such as Remel or BD BBL.  
There is a small card containing parallel black lines-  a Wickerham card. 
 
4.5.1. A 0.5 McFarland standard preparation 
 
1.   Add a 0.5-ml aliquot of a 0.048 mol/liter BaCl2 (1.175% wt/vol BaCl2 • 2H20) to 99.5 
ml of 0.18 mol/liter H2SO4 (1% vol/vol) with constant stirring to maintain a suspension. 
2.  Correct  density  verification of the turbidity standard by measuring absorbance using a 
spectrophotometer with a 1-cm light path and matched cuvette.The absorbance at 625 nm 
should be 0.08 to 0.13 for the 0.5 McFarland standards. 
3.  Barium sulfate suspension is transferred in the 4- to 6-ml aliquots into screw-cap tubes of 
the same size as those used in standardizing the bacterial inoculums. 
4. The tubes are sealed tightly and stored in the dark at room temperature.   
4.5.2. Use of the McFarland standard in the Kirby-Bauer procedure. 
1. Vigorous agitation of the barium sulfate standard on a mechanical vortex mixer and inspect 
for a uniformly turbid appearance.  Replace the standard if large particles appear. Standard is 
composed of latex particles, mix by inverting gently, not on a vortex mixer. 
2. Bacterial colonies was added to the saline in the “preparation of the inoculum” step of the 
procedure, should compare the resulting suspension to the McFarland standard.  By holding 
both the standard and the inoculum tubes  side by side comparison has been done and  the 
appearance of the lines through both suspensions the process is done.  Do not hold the tubes 
flush against the card.  If the bacterial suspension appears lighter than the 0.5 McFarland 
standards, more organisms should be added to the tube from the culture plate.  If the 
suspension appears denser than the 0.5 McFarland standards, additional saline should be 
added to the inoculums tube in order to dilute the suspension to the appropriate density.   
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4.6.   Preparation of Mueller-Hinton plate 
 
1.      Allow a MH agar plate undisturbed until it comes to the room temperature.  It is most 
important to allow the plates to remain in the plastic sleeve while they warm to minimize 
condensation. 
 
2.   Set the plate inverted, if the surface of the agar has visible liquid present, and place a jar 
on its lid to allow the excess liquid to drain from the agar surface and evaporate.  Plates may 
be placed in a 35°C incubator or in a laminar flow hood at room temperature until dry 
(usually 10 to 30 minutes). 
 
3. Label each of the  MH agar plate for each organism to be tested,  appropriately. 
 
4.7. Preparation of inoculum 
 
1.      Use sterile inoculating loop or needle and  touch four or five isolated colonies of the 
organism to be tested. 
2.      Suspend the organism in 2 ml of sterile saline. 
3.      Vortex the saline tube to create a smooth suspension. 
4.      By adjusting the turbidity of this suspension to a 0.5 McFarland standard by adding 
more organism if the suspension is too light or diluting with sterile saline if the suspension is 
too heavy. 
5.      Use this suspension within 15 minutes of preparation. 
4.8. Inoculation of the MH plate 
1.      Dip a sterile swab into the inoculums tube. 
2.      Rotate the swab against the side of the tube (above the fluid level) using firm pressure, 
to remove excess fluid.  The swab should not be dripping wet. 
3.      Inoculate the dried surface of a MH agar plate by streaking the swab three times over 
the entire agar surface; rotate the plate approximately 60 degrees each time to ensure an even 
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distribution of the inoculums . 
 
4.      Rim the plate with the swab to pick up any excess liquid . 
5.      Discard the swab into an appropriate container. 
6.      Leaving the lid slightly ajar, allow the plate to sit at room temperature at least 3 to 5 
minutes, but no more than 15 minutes, for the surface of the agar plate to dry before 
proceeding to the next step. 
4.9. Placement of the antibiotic disks  
1.  Antimicrobial-impregnated disks should  be placed on the surface of the agar, using either 
forceps to dispense each antimicrobial disk one at a time, or a multi disk dispenser to 
dispense multiple disks at one time.   
a.      To use a multi disk dispenser, place the inoculated MH agar plate on a flat surface and 
remove the lid . 
b.  The dispenser‟s placed over the agar plate and the plunger was firmly pressed once to 
dispense the disks onto the surface of the plate. 
c. Dispenser off the plate has been lift and using forceps sterilized by cleaning them with an 
alcohol pad or flaming them with isopropyl alcohol, touch each disk on the plate to ensure 
complete contact with the agar surface.  This should be done before replacing the petri dish 
lid as static electricity may cause the disks to relocate themselves on the agar surface or 
adhere to the lid. 
d.      Do not move a disk once it has contacted the agar surface even if the disk is not in the 
proper location, because some of the drug begins to diffuse immediately upon contact with 
the agar. 
e.      To add disks one at a time to the agar plate using forceps, place the MH plate on the 
template provided in this procedure .  Sterilize the forceps by cleaning them with a sterile 
alcohol pad and allowing them to air dry or immersing the forceps in alcohol then igniting. 
f.       Using the forceps carefully remove one disk from the cartridge . 
g.      Partially remove the lid of the petri dish.  Place the disk on the plate over one of the 
dark spots on the template and gently press the disk with the forceps to ensure complete 
contact with the agar surface. Replace the lid to minimize exposure of the agar surface to 
room air. 
h.      Continue to place one disk at a time onto the agar surface until all disks have been 
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placed as directed in steps f. and g. above. 
 
4.10.  Incubation of the plates 
Once all disks are in place, replace the lid, invert the plates, and place them in a 35°C air 
incubator for 16 to 18 hours.   
4.11. Measuring zone sizes 
1.      Following incubation, measure the zone sizes to the nearest millimeter using a ruler or 
caliper; include the diameter of the disk in the measurement. 
2.      When measuring zone diameters, always round up to the next millimetre. 
3.      All measurements are made with the unaided eye while viewing the back of the Petri 
dish.  Hold the plate a few inches above a black, non-reflecting surface illuminated with 
reflected light. 
4.      View the plate using a direct, vertical line of sight to avoid any parallax that may result 
in misreading. 
5.      Record the zone size on the recording sheet. 
6.      If the placement of the disk or the size of the zone does not allow you to read the 
diameter of the zone, measure from the center of the disk to a point on the circumference of 
the zone where a distinct edge is present (the radius) and multiply the measurement by 2 to 
determine the diameter. 
7.      Growth up to the edge of the disk can be reported as a zone of 0 mm. 
8.      Organisms such as Proteus mirabilis, which swarm, must be measured differently than 
no swarming organisms.  Ignore the thin veil of swarming and measure the outer margin in an 
otherwise obvious zone of inhibition. 
9.      Distinct, discrete colonies within an obvious zone of inhibition should not be considered 
swarming.  These colonies are either mutant organisms that are more resistant to the drug 
being tested, or the culture was not pure and they are a different organism.  If the 
phenomenon repeats itself  by repeat testing ,the organism must be considered resistant to 
that drug.  
4.12. Minimum Inhibitory Concentration Test (MIC Test): 
 A single microorganism‟s pure culture is grown in Mueller-Hinton broth, or other 
broth as appropriate. 
30 
 
 Standardized culture was prepared by using standard microbiological techniques to 
have a concentration of very near 1 million cells per millilitre. The more reproducible 
the test results are produced by using he more standard the microbial culture. 
 Diluted of the antimicrobial agent has been done a number of times, 1:1, through a 
sterile diluent (usually Mueller-Hinton broth). 
 After the antimicrobial agent has been diluted, a volume of the standardized 
inoculums equal to the volume of the diluted antimicrobial agent is added to each 
dilution vessel, bringing the microbial concentration to approximately 500,000 cells 
per millilitre. 
 Incubate the inoculated, serially diluted antimicrobial agent at a proper temperature 
for the test organism for a pre-set period, usually 18 hours. The more reproducible the 
test results were obtained by using the more standard the incubation period.  
 After incubation, the series of dilution vessels is observed for microbial growth, 
usually indicated by turbidity and/or a pellet of microorganisms in the bottom of the 
vessel. The last tube in the dilution series that does not demonstrate growth 
corresponds with the minimum inhibitory concentration (MIC) of the antimicrobial 
agent. 
 
4.13. PREPARATION OF SERIALLY DILUTED ANTIMICROBIAL 
AGENT: 
 
The antimicrobial agents are diluted to a number of times with ratio 1:1. The concentration of 
antibiotic in the solution is in microgram/mL. 
The quantity of antimicrobial agent to be taken for the preparation of a known concentration 
of antibiotic solution was carried out by using the following formula. 
 
                                                         VOLUME (mL) * Conc. (µg/mL) 
                           WEIGHT (mg) = --------------------------------------------- 
                                                                 POTENCY (µg/mg) 
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RESULTS 
5.1. Result Analysis: 
The characterization and identification of strain  was done by  using Hi 
Enterobacteriaceae for the identification of Enterobacteriaceae. Biochemical 
Identification test kit is a standardized colorimetric identification system 
utilizing conventional biochemical tests and carbohydrate utilization tests. The 
tests are based on the principle of pH change and substrate utilization.and the 
antimicrobial susceptibility profile was evaluated by the Kirby-Bauer technique. 
The minimum inhibitory concentrations (MICs) were determined by dilution  
technique. . On incubation organisms undergo metabolic changes which are 
indicated by a colour change in the media that is either interpreted visually or 
after addition of a reagent (Figs 12-14) 
                                                   
                           
Fig 12- E. coli identification                                       Fig 13- Bacillus identification 
 
                                            
                                        Fig 14- Klebsiella identification 
32 
 
Table 1: Enterobacteriaceae Identification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strip 1                                                            Result Entry Datasheet 
SL.NO           Test E. coli Bacillus Klebsiella 
1 ONPG + - + 
2 Lysine utilization + + + 
3 Ornithine utilization - + + 
4 Urease - - - 
5 Phenylalanine 
deamination 
- - - 
6 Nitrate reduction + + + 
7 H2S production - - - 
8 Citrate utilization - + + 
9 Voges proskauer‟s - - - 
10 Methyl red - - - 
11 Indole - - + 
12 Malonate utilization - - - 
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Strip 2                                                         Result Entry datasheet          
Sl.No Test E. coli Bacillus Klebsiella 
13 Esculin hydrolysis - + - 
14 Arabinose + - + 
15 Xylose + - - 
16 Adonitol - - - 
17 Rhamnose + - - 
18 Cellobiose - + - 
19 Melibiose + - + 
20 Saccharose + - - 
21 Raffinose + - - 
22 Trehalose + + - 
23 Glucose + + + 
24 Lactose + - + 
25 Oxidase - + - 
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Table 2 Carbohydrate utilization test 
SL.NO             TEST E. coli Bacillus Klebsiella 
PART A     
1 Lactose + - - 
2 Xylose + - - 
3 Maltose + + - 
4 Fructose + + - 
5 Dextrose + + + 
6 Galactose + + + 
7 Raffinose - - - 
8 Trehalose + + - 
9 Melibiose - - + 
10 Sucrose - - - 
11 L- arabinose - - + 
12 Mannose - + - 
PART B     
13 Inulin - - - 
14 Sodium gluconate + - - 
15 Glycerol + + + 
16 Salicin - + + 
17 Dulcitol - - - 
18 Inositol - - - 
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19 Sorbitol - - - 
20 Mannitol + - - 
20 Mannitol + - - 
21 Adonitol - - - 
22 Arabitol - - - 
23 Erythritol - - - 
24 α – methyl –D-glucoside - - - 
PART C     
25 Rhamnose - - + 
26 Cellobiose - - - 
27 Melezitose - - - 
28 α –methyl-D-mannoside - - - 
29 Xylitol + - - 
30 ONPG + - + 
31 Esculin hydrolysis - + + 
32 D-Arabinose + - + 
33 Citrate utilization - - - 
34 Malonate utilization - - - 
35 Sorbose + - - 
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5.2. RESULTS FOR ANTIBIOTIC DISK DIFFUSION TECHNIQUE: 
 
1. In this study of the isolates, the highest frequencies of antimicrobial-resistant  were 
observed for E. coli isolates from humans. Maximum resistance was  showed by E.coli  
towards all the antibiotic except chloramphenicol. Sensitive to chloramphenicol. 
2. Klebsiella showed 50% resistance towards antibiotics such as 
vancomycin,ciprofloxacin,amoxicillin. The rest 50% was sensitive towards antibiotic 
tetracycline,chloramphenicol and kanamycin. 
3. Bacillus shows resistance to most of the antibiotics used for antibiotic test such as 
tetracyclin,vancomycin,ciprofloxacin,kanamycin,chloramphenicol.  
 
Table 3 Antibiotic disk diffusion result. 
 
 
 
Table 4: Antibiogram of disk diffusion test 
 
 
 
   
Antibiotics 
 
 
organisms 
Tetracycline 
    (30 mcg) 
Vancomycin 
     (30mcg) 
Ciprofloxacin 
      (30mcg) 
Amoxicilin 
    (30mcg) 
Chloramphenicol 
           (30mcg) 
Kanamycin 
   (30mcg) 
E. coli Resistance Resistance Resistance Resistance        Sensitive resistance 
Klebsiella Sensitive Resistance Resistance Resistance        Sensitive    sensitive 
Bacillus Resistance Resistance Intermediate Resistance       Resitance Resistance 
organism antibiogram 
E.coli T
R
V
R
Cf
R
Am
R
C
S
K
R 
klebsiella T
S
V
R
Cf
R
Am
R
C
S
K
S 
Bacillus  T
R
V
R
Cf
I
Am
R
C
R
K
R 
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                        Fig 15: Bacillus ( Ciprofloxacin, chloramphenicol,tetracycline) 
 
                       
            Fig 16: Bacillus ( kanamycin,vancomycin,amoxicillin) Antibiotic disk diffusion identification 
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                               Fig 16: Klebsiella Antibiotic disk diffusion identification 
 
                                      
                                     Fig 17: E coli .Antibiotic disk diffusion identification. 
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5.4. Minimum inhibitory concentration  result: 
Conc- µg/ml 
Table  5: minimum inhibition  concentration test 
 
 
 
 
 
1. E.coli is resistance towards amoxicillin. 
2. Klebsiella is also resistance to amoxicillin. 
3. Bacillus was also found to  be resistance towards amoxicillin and penicillin. 
 
 
 
 
 
 
 
 
 
 
 Vancomycin       Penicillin Chloramphenicol amoxicillin 
E. coli 4 2              2        
Resiatance 
Klebsiella 4 2             16        
Resistance 
Bacillus 4 Resistance              2        
Resistance 
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Discussion: 
 
E. coli is defined as a Gram-negative, non-spore forming, rod-shaped micro-organism 
that is often motile by means of flagella or may be non-motile, and which can grow with or 
without oxygen. It is catalase positive, oxidase negative, fementative (glucose, lactose, D-
mannitol, arabinose and maltose), reduces nitrate and is β-galactosidase positive. 
Approximately 95 % of E. coli strains are methyl red positive, but are Voges-Proskauer and 
citrate negative Indole positive bacteria such as Escherichia coliproduce tryptophanase, an 
enzyme that cleaves tryptophan, producing indole and other products. E. colidoes not produce 
acetyl methyl carbinol, When Kovac's reagent (p-dimethylaminobenzaldehyde) is added to a 
broth with indole in it, a dark pink color develops. Pathogenic isolates of  E. coli has widely 
been implicated in various clinical infections as hospital coli have relatively high potentials 
for developing resistance. High resistance of E. Coli to antimicrobial agents tested was   
observed in this study and it was observed that E.coli has highest resistance to vancomycin, 
tetracyclines, kanamycin,ciprofloxacin,amoxcilin.It was also found that E.coli is sensitive 
towards  chloramphenicol. Beta-lactam antibiotics are widely used in the treatment of 
bacterial infections. However, the production of extended spectrum beta-lactamases (ESBLs), 
one of the resistance mechanisms encountered in Enterobacteriaceae, mainly Escherichia coli 
and Klebsiella pneumoniae, has been associated with several treatment failures.  Bacillus 
cereus responds positive towards citrates,lysine glucose ,ornithin,nitrate and oxidase.It is 
negative for indol methyl red and urease test. Klebsiella and Enterobacter produce more 
neutral products from glucose (e.g. ethyl alcohol, acetyl methyl carbinol). In this neutral pH 
the growth of the bacteria is not inhibited. The bacteria thus begin to attack the peptone in the 
broth, causing the pH to rise above 6.2. At this pH, methyl red indicator is a yellow color (a 
negative MR test). The citrate test utilizes Simmon's citrate media to determine if a bacterium 
can grow utilizing citrate as its sole carbon and energy source. Klebsiella pneumoniae are 
citrate positive. klebsiella  do not  produces H2S gas. It utilizes glucose as the sole source of 
carbon when grown on glucose rich medium.Antibiotic resistant E. coli isolates indicate the 
unwise and excessive consumption of antimicrobial drugs which in turn has brought about 
failure in treatment, and consequently concerns about the related issues. E. coli has widely 
been implicated in various clinical infections as hospital acquired and community infections 
as reported by Shah et al. (2002). Pathogenic isolates of E.coli have relatively high potentials 
for developing resistance (Karlowsky et al., 2004). High resistance of E. Coli to antimicrobial 
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agents tested was observed in this study. Data shows that the prevalence of resistance to most 
drugs tested in E. coli isolates. The greatest resistance in the present study was to tetracycline. 
The growing antimicrobial resistance may be due to unrational use of antibiotics and the 
transfer of resistance genes by transport means including antibiotic resistant plasmids, 
bacterio-phages, transposons and integrons. Since a plasmid or transposon can carry several 
resistance indexes, simultaneous resistance to multiple antimicrobial agents maybe developed 
and the result would be MDR organisms. For example, resistance to is usually accompanied 
by resistance to Tetracycline. 
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CONCLUSION 
 
Resistance to antimicrobial drugs increased based on the evolution of bacteria, including 
multidrug resistance, is unavoidable because it represents a particular aspect of the general 
evolution of bacteria that is unstoppable. Delay the emergence of resistant bacteria or 
resistance genes or dealing with this situation. Mutations in housekeeping structural or 
regulatory genes in bacteria increases resistance to antimicrobial drugs. Alternatively, the 
horizontal acquisition of foreign genetic information can give rise to the resistance. The 2 
phenomena are associated in the emergence and more efficient spread of resistance. .The 
resistant strains produce “extended-spectrum beta-lactamases”, enzymes that destroy 
penicillin .These very common bacteria, are much harder to kill with antibiotics, when they 
produce these enzymes. 
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Future prospects 
1 Antimicrobial susceptibility enhancement using agents . 
2 Phage therapies, an approach that has been extensively researched and utilized as a 
therapeutic agent. Bacteriophages or "phages" are the viruses that invade bacterial cells and, 
in the special case of the lytic phages, they disrupt bacterial metabolism and cause the 
bacterial lysis . The therapeutic use of lytic bacteriophages is the phase therapy- to treat the 
pathogenic bacterial infections. 
3 Emergence and increasing prevalence of bacterial strains that are very much resistant to 
available antibiotics that helps in the discovery of new therapeutic approaches.  
4 An alternative approach for targeting bacterial virulence is antimicrobial therapy that offers 
promising opportunities to inhibit pathogenesis.  
5 Certain virulence factors are very good potential targets for drug design and therapeutic 
intervention, whereas new insights are crucial for exploiting others. Targeting virulence is 
representing a new way to empower the clinician to prevent and treat infectious diseases. 
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APPENDIX I 
Nutrient agar  
Ingredients                   Gms / Litre 
Peptic digest of animal tissue 5.000 
Sodium chloride 5.000 
Beef extract 1.500 
Yeast extract 1.500 
Agar 15.000 
Final pH ( at 25°C) 7.4±0.2 
Muller-Hinton agar 
For 1 liter of medium:  
- Acid hydrolysate of casein .............................................................17.5 g  
- Beef infusion ....................................................................................2.0 g  
- Soluble starch ..................................................................................1.5 g  
- Bacteriological agar .......................................................................17.0 g  
pH of the ready-to-use medium at 25°C : 7.3 ± 0.2 
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APPENDIX II 
 
0.5 McFarland standard 
Sulphuric Acid ,1%                         995.00 ml 
Barium Chloride, 1%                      5.00kovac 
 
Kovac’s reagent 
 p-Dimethylaminobenzaldehyde  7 4.8%  
Isoamyl Alcohol      4.8%  
Hydrochloric Acid   23.8% 
 
TDA reagent 
Ferric chloride 10g/100ml (in distilled water) 
Baritt reagent 
Methyl reagent 
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